{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:13:43Z","timestamp":1784754823125,"version":"3.55.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":1671,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Patients with a history of chemotherapy or stem cell transplantation (SCT) and prolonged neutropenia are at risk for hepatic and\/or splenic seeding of Candida. In our experience, hepatosplenic candidiasis (HSC) without documented candidemia often remains unrecognized.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case presentations<\/jats:title>\n                  <jats:p>We describe three cases of HSC without documented candidemia and the challenges in establishing the diagnosis and adequately treating this condition. The first patient had a history of SCT for treatment of breast cancer and was scheduled for hemihepatectomy for suspected liver metastasis. A second opinion at our institute resulted in the diagnosis of hepatic candidiasis without prior documented candidemia, for which she was treated successfully with fluconazole. The second case demonstrates the limitations of (blood and tissue) cultures and the value of molecular methods to confirm the diagnosis. Case 3 illustrates treatment challenges, with ongoing dissemination and insufficient source control despite months of antifungal therapy, eventually resulting in a splenectomy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Literature review<\/jats:title>\n                  <jats:p>A structured literature search was performed for articles describing any patient with HSC and documented blood culture results. Thirty articles were available for extraction of data on candidemia and HSC. Seventy percent (131\/187) of patients with HSC did not have documented candidemia. The majority of HSC events were described in hematologic patients, although some cases were described in patients with solid tumors treated with SCT (n\u2009=\u20091) or chemotherapy and a history of leukopenia (n\u2009=\u20092). Current guidelines and practices for diagnosis and treatment are described.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Clinicians should be aware that HSC most often occurs without documented candidemia. In case of persistent or unexplained fever or lesions in the liver and\/or spleen, a history of neutropenia should place disseminated candidiasis in the differential diagnosis. HSC is not limited to hematological patients and may occur in patients with solid tumors treated with bone marrow-suppressing chemotherapy or SCT. In the latter group, HSC as alternative diagnosis for hepatic metastasis should be considered when lesions are not typical for metastasis. This might prevent unnecessary surgery or inappropriate treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2017-0019","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T01:20:26Z","timestamp":1493860826000},"page":"989-994","source":"Crossref","is-referenced-by-count":19,"title":["Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis?"],"prefix":"10.1093","volume":"22","author":[{"given":"Joffrey","family":"van Prehn","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Willemien","family":"Menke-van der Houven van Oordt","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelon L.","family":"de Rooij","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Meijer","sequence":"additional","affiliation":[{"name":"Department of Hematology VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije K.","family":"Bomers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"van Dijk","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"key":"2021122508141833000_onco12124-bib-0001","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive Candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"2021122508141833000_onco12124-bib-0002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures","volume":"18","author":"Cuenca-Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2021122508141833000_onco12124-bib-0003","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/CCM.0b013e31819efac0","article-title":"Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006)","volume":"37","author":"Leroy","year":"2009","journal-title":"Crit Care Med"},{"key":"2021122508141833000_onco12124-bib-0004","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/clinids\/24.3.375","article-title":"Hepatosplenic candidiasis in patients with acute leukemia: Incidence and prognostic implications","volume":"24","author":"Anttila","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2021122508141833000_onco12124-bib-0005","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1365-2141.1999.01592.x","article-title":"Hepatosplenic candidiasis in patients with acute leukaemia","volume":"106","author":"Sallah","year":"1999","journal-title":"Br J Haematol"},{"key":"2021122508141833000_onco12124-bib-0006","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/j.1439-0507.2012.02182.x","article-title":"New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis","volume":"55","author":"Rammaert","year":"2012","journal-title":"Mycoses"},{"key":"2021122508141833000_onco12124-bib-0007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.00053-10","article-title":"Histopathologic diagnosis of fungal infections in the 21st century","volume":"24","author":"Guarner","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"2021122508141833000_onco12124-bib-0008","doi-asserted-by":"crossref","first-page":"E185","DOI":"10.1111\/j.1469-0691.2012.03819.x","article-title":"Hepatosplenic candidiasis in the era of new antifungal drugs: A study in Paris 2000-2007","volume":"18","author":"Castro","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2021122508141833000_onco12124-bib-0009","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: How nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2021122508141833000_onco12124-bib-0010","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2021122508141833000_onco12124-bib-0011","doi-asserted-by":"crossref","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: Adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2021122508141833000_onco12124-bib-0012","doi-asserted-by":"crossref","first-page":"88","DOI":"10.7326\/0003-4819-108-1-88","article-title":"Hepatic candidiasis in cancer patients: The evolving picture of the syndrome","volume":"108","author":"Thaler","year":"1988","journal-title":"Ann Intern Med"},{"key":"2021122508141833000_onco12124-bib-0013","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0924-8579(96)00306-8","article-title":"Hepatosplenic candidiasis in non-neutropenic patients: A case report and literature survey","volume":"7","author":"Spindel","year":"1996","journal-title":"Int J Antimicrob Agents"},{"key":"2021122508141833000_onco12124-bib-0014","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2017-0019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2017-0019","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/22\/8\/989\/41914152\/oncolo_22_8_989.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/22\/8\/989\/41914152\/oncolo_22_8_989.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T08:15:22Z","timestamp":1640420122000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/22\/8\/989\/6444405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":14,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,5,3]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2017-0019","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8,1]]},"published":{"date-parts":[[2017,5,3]]}}}